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The recent sequencing of the 
 
Drosophila
 
 genome as a col-
laborative effort between the Berkeley 
 
Drosophila
 
 Ge-
 
nome Project (BDGP)
 
1
 
 and Celera Genomics provides an
unparalleled opportunity to assess the prevalence of human
disease gene counterparts in the fly genome (Adams et al.,
2000; Rubin et al., 2000). Previous surveys based upon lim-
ited data available during earlier phases of the sequencing
 
project have suggested that 
 
.
 
50%, and perhaps as many as
75%, of human disease genes are conserved in 
 
Drosophila
 
(Banfi et al., 1996; Berkeley 
 
Drosophila
 
 Genome Project,
1999; Pickeral et al., 2000). With the virtually complete se-
quence now in hand, we were able to perform a more com-
prehensive survey, resulting in the finding that 178 out of
287 human disease genes (62%) appear to be conserved in
the fly (Rubin et al., 2000). The major findings of this survey
have been presented and briefly discussed (Rubin et al.,
2000). Here we describe in more detail the manner in which
we conducted this survey, and the limitations of large-scale
computational methods for whole-genome searches of this
type. We summarize the results of our searches for several
different categories of human disease genes in the fly, and
their implications for the utility of 
 
Drosophila
 
 for the analy-
sis of human disease gene function.
 
Survey Design and Methodology
 
Constructing the Human Disease Gene List
 
The core component of our survey is a list of 287 human
disease genes representing several different classes of dis-
eases, including cancer, neurological diseases, cardiovas-
cular diseases, malformation syndromes, hematological,
immune, endocrine, renal, and metabolic disorders (Table
I). This list was compiled by scanning the Online Men-
delian Inheritance in Man database (OMIM; http://
www.ncbi.nlm.nih.gov/omim/) as well as medical text-
books and review articles listing classes of human disease
genes. The criterion for inclusion in the final list was that
the human gene must actually be mutated, altered, ampli-
fied, or deleted in human subjects with the disease. From
 
our initial set of 
 
.
 
800 human genes associated with dis-
eases, over half were eliminated because they did not meet
this criterion. Genes potentially linked to a human disease
solely by cell culture experiments, yeast two-hybrid inter-
action screens, model organism studies, or similar ap-
proaches were excluded from our analysis. Each human
disease gene on the final list was confirmed by checking
OMIM or published literature sources, and was placed in
the most relevant disease category on the list. For human
disease genes in which different paralogs have been associ-
ated with disease, such as Ras family members, rhodop-
sins, and some HOX and PAX gene family members, a
single example was chosen to represent the group and re-
dundant paralogs were eliminated from the list. In some
cases, assignment of a gene to a particular category was
somewhat arbitrary, since altered gene function may result
in different diseases or a syndrome characterized by multi-
ple organ involvement or a complex pathophysiology. For
example, human 
 
Notch
 
 gene mutations cause both cancer
(
 
Notch1
 
 rearrangements in T cell acute lymphoblastic leu-
kemia) and neurological disease (
 
Notch3
 
 point mutations
in CADASIL). The final list of 287 human disease genes is
not meant to be comprehensive; in fact, there are currently
estimated to be 1,000 human disease genes defined by at
least one allelic variant each (Antonarakis and McKusick,
2000). However, our list does represent a large set of genes
mutated in a wide variety of human diseases, adjusted to
prevent biasing the survey towards certain common gene
families.
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Bulk BLAST Searches and Analysis
 
The initial step in the survey was to perform bulk
BLASTP searches in which the 287 human disease protein
sequences were used as queries to search a database con-
sisting of all predicted proteins encoded by the yeast,
worm, and fly genomes (38,860 total sequences; Rubin et al.,
2000). To control for potential frameshift errors in the
 
Drosophila
 
 genomic sequence, which might result in an
open reading frame of one actual gene being split and as-
signed to two or more predicted genes, searches against
a six-frame translation of the entire genome using
TBLASTN were also conducted with the disease gene
query sequences. Only two cases were detected in which
matches to the genomic sequence were better than to the
predicted protein data set.
These BLAST searches provided us with an initial set of
BLAST scores and amino acid sequence alignments of each
human disease protein to the top five matches in each of
the three fully sequenced genomes. To assess the likeli-
hood that a given human disease protein has a counterpart
encoded in the fly genome, each set of alignments was vi-
sually inspected and compared with one another across
the different species. Since the bulk BLAST searches were
done with an aggregate set of 38,860 target sequences
representing all yeast, worm, and fly proteins, using a nor-
malized database size setting equal to the largest possible
proteome size for all three genomes combined (the z pa-
rameter in BLAST, derived by adding the nucleotide
lengths of all the genomes and dividing by three), the re-
sulting E values in the different organisms could be com-
pared directly despite their nonequivalent genome sizes.
Cross-species inspection of the best alignments for each
query protein aided our judgments by revealing whether
specific protein domains tend to be highly conserved in all
species, whether the fly possesses a much better match to
the query than do yeast and worm, and whether a clear
pattern of conserved residues can be discerned in the best
alignments from the different species. In addition, the
overall domain compositions of some fly proteins were
compared with their human query proteins using InterPro,
a database of protein sequence motifs (Apweiler et al.,
 
1999). Supporting biological information, such as pub-
lished reports of known fly and human gene homologues
as well as the consensus opinion of the 
 
Drosophila
 
 re-
search community, was also taken into consideration. For
example, many human disease genes were already known
to be homologous (and in some cases named after) well-
characterized fly genes, including 
 
patched
 
 (basal cell nevus
syndrome), 
 
Sonic hedgehog
 
 (holoprosencephaly 3), 
 
PAX6
 
(aniridia), 
 
Notch3
 
 (CADASIL multi-infarct dementia),
 
Jagged1
 
 (Alagille syndrome), 
 
Twist
 
 (Saethre-Chotzen syn-
drome), 
 
GLI3
 
 (Greig cephalopolysyndactyly), 
 
Diapha-
nous 1
 
 (autosomal dominant deafness), and 
 
Eyes absent 1
 
(Melnick-Fraser brachiootorenal dysplasia).
 
Evaluation of Questionable Cases
 
The above strategy allowed 
 
z
 
200 of the 287 genes on the
list to be scored as present or absent in the fly genome in a
relatively straightforward manner. For 
 
z
 
90 genes, how-
ever, the analysis was more problematic. For some of
these cases, the query protein sequence was very short or
the level of amino acid identity in the best BLAST align-
ments was not very impressive, resulting in a poor E value.
A particularly striking example is the fly p53 gene, which
exhibits a low degree of similarity to human p53 family
members (E value 
 
5 
 
2 
 
3
 
 10
 
2
 
8
 
), but which was judged to
be a homologue because it shows a conserved organization
of functional domains, and its DNA-binding domain con-
tains conserved residues at positions that are commonly
mutated in human cancers (Walker et al., 1999). In other
cases, fly proteins with very high similarity to the human
query sequence, often over a considerable portion of the
protein, were considered nonhomologous due to their dif-
ferent domain organization. The best fly protein alignment
to the von Willebrand Factor (VWF) protein, for example,
extended over much of the query sequence and had an E
value of 1 
 
3
 
 10
 
2
 
106
 
. However, the 
 
Drosophila
 
 protein lacks
the VWF type A domains that are crucial for the function
of the human protein (Fig. 1). For the fly protein most sim-
ilar to human E-cadherin (implicated in gastric cancer),
supporting biological evidence for the fly protein led us to
conclude that it should be considered a cadherin homo-
logue even though its domain structure is not quite identi-
cal to mammalian E-cadherin.
A common problem that arose in the large-scale
BLAST searches was that many human disease proteins
belong to large families of closely related yet functionally
distinct proteins, such as kinases, cell adhesion molecules,
and certain classes of transcription factors. Inspection of
BLAST scores and alignments was often insufficient to de-
termine whether the most related protein detected in a
given species represents a true homologue or merely a re-
lated protein. 
 
Drosophila
 
 possesses 
 
z
 
300 protein kinases
and 
 
.
 
100 homeodomain proteins, for example, and identi-
fication of many of these proteins as exact homologues to
known proteins in other organisms is often not possible
(Rubin et al., 2000). A particular kinase or homeodomain
protein implicated in human disease was not considered
by us to possess a 
 
Drosophila
 
 homologue simply because
it shows some similarity to various fly kinases or homeo-
domain proteins, without convincing conservation beyond
the generic kinase or homeodomain motifs. In these cases,
Figure 1. InterPro alignment of VWF to the protein that it most
resembles in the Drosophila genome. Representation of domains
of the human VWF protein and the most similar predicted
Drosophila protein (not drawn to scale). The Drosophila ORF
with the best sequence similarity to human VWF (bottom) has
several VWF-C domains (black), a VWF-D domain (gray), and a
very low E value when aligned to human VWF (top). However, it
has no VWF-A domains (white), which bind GPIIb, collagen and
heparin, and are crucial for the function of the human protein.
Thus the Drosophila predicted protein is unlikely to represent a
true homologue of human VWF. 
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Table I. Summary of the Human Disease Gene Survey in Drosophila
 
The 287 human disease genes are grouped according to disease classification, with genes that possess likely 
 
Drosophila
 
 homologues listed in the lefthand column and genes
that lack apparent 
 
Drosophila
 
 homologues listed in the righthand column within each disease category. In most cases, the disease name is given, followed by the human gene
abbreviation in parentheses, although some cancer genes are listed by gene name only due to their pleiotropic involvement in numerous cancers. Additional information about
this survey, including the GenBank accession numbers, OMIM numbers, and BLAST E value scores for the human disease genes tested can be found in Rubin et al. (2000)
and at http://www.sciencemag.org/feature/data/1049664t1.shl. Our current estimate of 178 out of 287 disease gene homologues in the fly genome differs slightly from the
estimate of 177 out of 289 reported in Rubin et al. (2000) due to the deletion of two redundant entries in the initial survey (CDKN2C and P16-INK4A; see Fig. 1 of Rubin et
al., 2000), and the transfer of the Von Hippel Lindau (VHL) gene into the homologue detected category. 
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it was useful to perform reverse BLAST searches, in which
the best fly candidate homologues were used as query se-
quences to search a database of all available human se-
quences. If the fly protein showed a significantly better
match to the original human query than to other related
proteins, we considered it to be a likely homologue. This
approach was successful in confirming that 
 
Drosophila
 
 has
homologues of Peutz-Jeghers kinase, leutenizing hor-
mone/choriogonadotropin receptor precursor (mutated in
Leydig cell hypoplasia), Wolfram syndrome protein, Kall-
mann disease protein, and numerous other human disease
proteins.
 
Limitations of the Analysis
 
In any large-scale computational survey of this type, it is
inevitable that some inaccuracies and errors will arise. Al-
though we performed extensive manual cross-checking of
our results, our effort should be considered a first-pass sur-
vey of human disease-related loci in 
 
Drosophila
 
, which
will be corrected and refined as the completed fly genome
sequence is further analyzed. Certain aspects of the se-
quence data would be expected to cause potential homo-
logues to be missed. The genome sequence currently con-
tains 
 
.
 
1,000 relatively small gaps, some of which could
contain disease gene homologues that we failed to detect.
The Machado-Joseph disease gene (
 
SCA3/MJD
 
) has an
identified homologue in 
 
C
 
.
 
 elegans
 
 but not in 
 
D
 
.
 
 melano-
gaster
 
, for example, suggesting that a fly counterpart could
exist but might have gone undetected in our survey. Fur-
thermore, the gene prediction algorithms used to analyze
the fly genome sequence are known to be error-prone, in-
correctly predicting 5
 
9
 
 and 3
 
9
 
 coding exons and intron–
exon boundaries, splitting single genes into two or more
predicted genes, and merging adjacent genes into a single
predicted transcript (Reese et al., 2000). Such errors might
be expected to result in artificially lower BLAST scores,
incorrect domain organizations for some predicted pro-
teins, or even the failure of an actual fly protein to be pre-
dicted with enough accuracy to be detected at all by our
BLAST search protocol. Finally, for human disease genes
that have not been well studied or are completely novel,
the lack of supplementary data makes it difficult to evalu-
ate manually the BLAST alignments and InterPro domain
structure predictions, or to use other biological clues to
guide the analysis.
 
Results of the Survey
 
In our survey of 287 human disease genes, a total of 178
(62%) were found to have likely homologues in 
 
Dro-
sophila
 
. Inspection of the different classes of genes indi-
cates that some categories are better represented than oth-
ers (Table I). Categories with a high representation of
homologues in 
 
Drosophila
 
 include the genes for cancer
(47 of 65, 72%), neurological diseases (38 of 59, 64%),
malformation syndromes (22 of 34, 65%), metabolic dis-
eases (14 of 17, 82%) and renal diseases (11 of 16, 69%). A
small number of genes implicated in cardiac diseases all
had likely homologues in 
 
Drosophila
 
 (6 of 6). Underrepre-
sented in the fly genome were likely homologues of the
genes implicated in endocrine (12 of 31, 39%) and hema-
 
tological diseases (8 of 18, 44%) as well as diseases of the
immune system (7 of 17, 41%).
 
Cancer Genes in Drosophila
 
A high proportion of cancer genes have homologues in
 
Drosophila
 
. Many of these homologues have been identi-
fied by workers in the field who have cloned these genes
using hybridization to mammalian sequences or more re-
cently by searching for sequence similarity in databases of
 
Drosophila
 
 genomic sequence or EST sequences. Our first
look at the complete sequence of the genome allowed us
to identify additional homologues and also to make tenta-
tive statements about classes of cancer genes that appear
to be absent in 
 
Drosophila
 
. Two groups of cancer genes
that appear to be absent in 
 
Drosophila
 
 are the genes mu-
tated in breast cancer (
 
BRCA1
 
 and 
 
BRCA2
 
) and the
genes mutated in Fanconi’s anemia (
 
FANCA
 
, 
 
FANCC
 
,
and 
 
FANCG
 
), a disease characterized by anemia, chromo-
somal instability and a predisposition to cancer. Also ap-
parently absent are homologues of 
 
mdm2
 
 and 
 
p19ARF
 
 (or
 
p14ARF
 
) which regulate the levels of the p53 protein in
mammalian cells (Pomerantz et al., 1998; Zhang et al., 1998).
One of the genes identified as a result of the sequencing
effort is a convincing homologue of the human 
 
menin
 
 gene
(
 
MEN1
 
). Mutations in 
 
menin
 
 are found in the multiple en-
docrine neoplasia type 1 syndrome, a familial cancer syn-
drome characterized by varying combinations of tumors in
the parathyroid glands, the pancreatic islets, the anterior
pituitary, as well as a variety of other tissues. These tumors
often secrete the hormones of the tissue of origin (e.g., in-
sulin and growth hormone). The 
 
menin
 
 gene encodes a nu-
clear protein of 610 amino acids which is thought to bind
to and inhibit the function of the JunD transcription factor
in humans (Agarwal et al., 1999). The biological function
of Menin and the relationship between 
 
menin
 
 mutations
and endocrine tumors are poorly understood. An align-
ment of the human and the putative 
 
Drosophila
 
 Menin
proteins is shown in Fig. 2. The proteins display 34% iden-
tity and 47% similarity over their entire length. Of a panel
of eleven naturally occurring germline or somatic missense
mutations in 
 
MEN1
 
 (Agarwal et al., 1999), ten affect resi-
dues that are conserved in the 
 
Drosophila
 
 protein, sug-
gesting that residues crucial for function are conserved be-
tween the two proteins. In contrast, the 
 
C
 
.
 
 elegans
 
 genome
does not appear to have a 
 
menin
 
 homologue.
Also identified in our survey was a 
 
Drosophila
 
 p53 fam-
ily member, the sequence and function of which have been
described in two recent publications (Brodsky et al., 2000;
Ollmann et al., 2000). The levels of mammalian p53 are
thought to be regulated by two distinct pathways. One in-
volves Mdm2 and p19ARF, which do not appear to have
homologues in the 
 
Drosophila
 
 genome, as noted above.
The second pathway, which leads to the phosphorylation
of p53, appears to be activated in response to DNA dam-
age and involves the ATM and Chk2 kinases (reviewed by
Caspari, 2000). Homologues of the 
 
ATM
 
 and 
 
chk2
 
 genes
are clearly found in 
 
Drosophila
 
, indicating that this path-
way may represent the more evolutionarily ancient mode
of p53 regulation. Consistent with this notion, 
 
Drosophila
 
p53 appears to be necessary for apoptosis in response to
DNA damage (Brodsky et al., 2000; Ollmann et al., 2000). 
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Furthermore, only one p53-related protein is predicted in
the fly genome, indicating that it may represent an ances-
tral prototype of the mammalian p53/p63/p73 family.
Mutations in the two related genes 
 
EXT1
 
 and 
 
EXT2
 
have been implicated in human multiple exostosis syn-
dromes, which are characterized by abnormal bony out-
growths. The 
 
Drosophila
 
 homologue of 
 
EXT1
 
 is the 
 
tout-
 
velu
 
 gene, which has been shown to be necessary for the
diffusion of the Hedgehog protein that functions as a mor-
phogen in many tissues (Bellaiche et al., 1998). The se-
quencing effort has identified a homologue of the 
 
EXT2
 
gene. One might speculate that this 
 
EXT2
 
 homologue may
have a role in facilitating the diffusion of Hedgehog or
perhaps a different morphogen, such as a Wnt protein
family member, in 
 
Drosophila
 
 tissues.
A likely homologue of the STK11 kinase was also iden-
tified (Fig. 3). This gene is mutated in Peutz-Jeghers dis-
ease (Jenne et al., 1998), in which affected individuals
present clinically with oral pigmentation and multiple in-
testinal polyps. Its mechanism of action and likely sub-
strates are not known, and the identification of a 
 
Dro-
sophila
 
 homologue should enable genetic screens analogous
to those that have been employed to successfully identify
signaling components downstream of protein kinases such
as Sevenless and Raf (Simon et al., 1991; Dickson et al.,
1996).
Ataxia telangiectasia (ATM) is a syndrome character-
ized by loss of coordination (ataxia) as well as multiple cu-
taneous capillary malformations (telangiectasia). The gene
product of the 
 
ATM
 
 locus has been implicated in activat-
ing signaling pathways in response to DNA damage. The
Drosophila  mei-41 gene has previously been shown to
function as an ATM homologue in many respects (Hari
et al., 1995). The Drosophila genome contains an addi-
tional gene identified by the genomic sequencing effort
that appears to be more similar to ATM than is mei-41
(Sekelsky et al., 2000). Thus these two genes in Drosophila
may have roles analogous to those of the ATM and the
ATM-related (ATR) genes in mammals.
Neurological Genes in Drosophila
Out of 59 human neurological genes surveyed, 38 appear to
be conserved in Drosophila (Rubin et al., 2000). Several of
these genes were previously identified by molecular genetic
studies in the fly, such as Notch (CADASIL syndrome),
Presenilin (Alzheimer’s disease), Amyloid protein precur-
sor-like (Alzheimer’s disease), diaphanous (nonsyndromic
deafness, premature ovarian failure), Superoxide dismutase
1 (amyotrophic lateral sclerosis), rhodopsin kinase (Oguchi
stationary nightblindness type 2), and huntingtin (Hunting-
ton’s disease). Functional studies of these fly loci have al-
ready provided insights into the molecular mechanisms reg-
ulated by their mammalian counterparts, in some cases
recapitulating aspects of human neurological disorders and
aging with startling fidelity (reviewed in Fortini and Bonini,
2000). The genome sequencing project has uncovered a
number of additional fly homologues for other important
neurological disease loci, holding promise for similarly in-
formative analyses of these genes in Drosophila. Among
the most highly conserved neurological disease genes in the
fly are loci implicated in adrenoleukodystrophy (ABCD1),
Angelman syndrome (UBE3A), Best macular dystrophy
(VMD2), Duchenne muscular dystrophy (DMD), Emery-
Dreifuss muscular dystrophy (LMNA), Fragile-X syndrome
(FMR1), Limb girdle muscular dystrophy 2A and 2B
(CAPN3 and DYSF), Lowe oculocerebrorenal syndrome
(OCRL), Miller-Dieker lissencephaly (PAF), juvenile-
onset Parkinson’s disease (Parkin), Stargardt disease
Figure 2. Alignment of the human and Drosophila Menin pro-
teins. The human (bottom line) and Drosophila (top line) Menin
proteins were aligned using the MacVector 6.5 ClustalW pro-
gram with the BLOSUM 30 matrix and an open gap penalty of
10. The fly protein is 34% identical and 47% similar to the human
protein over its entire length.The Journal of Cell Biology, Volume 150, 2000 F28
(ABCA4), and Tay-Sachs disease (HEXA). Our survey also
identified a less well conserved yet convincing homologue
of the human tau gene, mutations in which have recently
been found to cause frontotemporal dementia with parkin-
sonism (reviewed in Lee and Trojanowski, 1999).
Also worth noting are the human neurological disease
loci that we failed to detect in the fly genome. We were un-
able to find a fly counterpart of human prion protein gene
(PRNP), despite extensive BLAST searches using differ-
ent prion protein segments, or homologues of the Charcot-
Marie-Tooth syndrome 1A and 1B loci, or the Parkinson's
disease gene encoding a-synuclein. Directed neuronal ex-
pression of human a-synuclein in aged transgenic flies
leads to the formation of Lewy bodies and other morpho-
logical defects reminiscent of human Parkinson’s disease
(Feany and Bender, 2000), indicating that the cellular
mechanisms involved in Parkinson’s disease neuropatho-
physiology may be conserved in Drosophila even though
a-synuclein itself may be absent.
Several genes implicated in expanded polyglutamine re-
peat diseases, including huntingtin, FRDA (Friedreich
ataxia),  SCA2 and SCA6 (spinal cerebellar ataxia loci)
are conserved in the Drosophila genome, although oth-
ers, such as putative homologues of SCA1, SCA3/MJD
(Machado-Joseph Disease) and SCA7 were not found.
Transgenic  Drosophila models of expanded polyglutamine
repeat diseases have already been developed by directed
expression of human Huntingtin and SCA3/MJD proteins
and shown to reproduce the nuclear inclusions of ex-
panded repeat proteins that are characteristic of this class
of illness (Jackson et al., 1998; Warrick et al., 1998). The
identification of single-copy fly homologues of different
expanded polyglutamine repeat genes raises the possibility
of using Drosophila genetics to eliminate the function of
the endogenous fly proteins. Such an approach should
help elucidate the normal activities of these proteins and
to determine whether the loss of normal protein activity
may contribute to human disease pathophysiology, inde-
pendent of or in conjunction with the expanded poly-
glutamine repeat inclusions. Moreover, the ability to pro-
duce easily observable phenotypes in Drosophila by either
mutagenesis or overexpression of human disease homo-
logues will allow the powerful genetic screening methods
of this organism to be exploited to help identify protein
partners and biochemical pathways involved in human
pathophysiology. This approach has already met with some
early successes, such as the suppression of polyglutamine
repeat expansion-induced phenotypes by overexpression
of molecular chaperones in Drosophila (Warrick et al.,
1999; Kazemi-Esfarjani and Benzer, 2000).
Malformation Syndrome and Metabolic Disorder Genes 
in Drosophila
Almost two thirds of the genes implicated in malformation
syndromes have likely Drosophila homologues. This find-
ing is not surprising since many of these genes function in
defining the body plan in the embryo and in patterning
specific tissues. Indeed, some of these genes were origi-
nally cloned by virtue of their sequence similarity to pat-
terning genes in Drosophila. These include the Sonic
hedgehog gene (holoprosencephaly 3) and the Eyes absent
1 (EYA1) gene which is mutated in Melnick-Fraser bra-
chiootorenal dysplasia. Also frequently conserved were
genes implicated in diseases caused by abnormalities in
metabolism, presumably reflecting a conservation of many
of the metabolic pathways between Drosophila and hu-
mans. Surprisingly, a likely homologue for the gene impli-
cated in Lesch-Nyhan syndrome, hypoxanthine guanine
phosphoribosyl transferase (HPRT1), was not found in the
fly genome sequence. C. elegans appears to have an HPRT
homologue, and many other enzymes involved in purine
biosynthesis in mammals have Drosophila homologues.
Our failure to detect a fly HPRT homologue might there-
fore represent a likely candidate for a gene that lies in one
of the small gaps still remaining in the assembled Dro-
sophila genome sequence.
Hematological and Immune Disease Genes
in Drosophila
Genes that function in the mammalian immune system
and in mammalian blood cells are significantly underrep-
resented in Drosophila. Not surprisingly, genes that func-
tion in acquired immunity, such as RAG1 and RAG2,
which are involved in immunoglobulin gene rearrange-
Figure 3. Alignment of the human and Drosophila Peutz-Jeghers
STK11 kinases. The human (bottom line) and Drosophila (top
line) Peutz-Jeghers disease STK11 kinases were aligned using the
MacVector 6.5 ClustalW program with the BLOSUM 30 matrix
and an open gap penalty of 10. The fly protein is 43% identical
and 56% similar to the human protein over its entire length.Fortini et al. Conservation of Human Disease Genes in Drosophila F29
ment, are not found in Drosophila. The absence of RAG-
like proteins is consistent with the fact that the Drosophila
genome is not known to undergo any programmed DNA
rearrangements, unlike several lower organisms such as
yeast and bacteria or the mammalian immune system. In
contrast, some of the genes that function in signaling path-
ways in hematopoietic cells, including BTK and JAK3,
possess  Drosophila homologues. Genes that function in
oxygen transport via erythrocytes, such as the hemoglobin
genes, and genes involved in blood coagulation do not
have Drosophila homologues, reflecting fundamental dif-
ferences in physiology between the two organisms. Flies
do not possess a hemoglobin-based oxygen delivery sys-
tem or clotting system resembling those of human blood,
and they instead rely upon a branching tracheal system
in which oxygen is delivered directly to tissues from the
atmosphere, and in which soft tissues are protected from
injury by a durable exoskeleton. However, human hema-
tological disease genes that encode components or likely
regulators of the cytoskeleton, such as the genes for
Wiskott-Aldrich syndrome (WAS) and hereditary sphero-
cytosis (ANK1), do possess Drosophila homologues.
Endocrine and Renal Disease Genes in Drosophila
Of the genes implicated in endocrine disorders, many com-
ponents of insulin-mediated signaling pathways are found in
Drosophila. Most other endocrine pathways do not appear
to be conserved. Finally, despite major dissimilarities be-
tween the vertebrate kidney and insect Malpighian tubules,
a significant proportion of genes mutated in congenital re-
nal disorders have Drosophila homologues. Many of these
genes encode proteins involved in fluid and electrolyte
transport and their identification might encourage the study
of Malpighian tubule development and function to gain in-
sight into certain human kidney disorders.
In conclusion, Drosophila appears to represent a partic-
ularly good model organism for the study of genes impli-
cated in many cancers, neurological disease, malformation
syndromes, metabolic disorders and some renal diseases.
Specific endocrine, immunological and hematological dis-
ease genes may require vertebrate model organisms such
as mice, since relatively few of the known human disease
genes in these categories are present in Drosophila. Most
promisingly, our search for fruit fly homologues of 287
known human disease genes leads us to conclude that as
additional human disease genes are discovered, it is more
likely than not that a counterpart will be found in the
Drosophila genome.
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